Intravascular deposits of fibrin have been noted in histological sections of rejected renal transplants (Porter 1967) . In this study radioactive fibrinogen was administered to human transplant recipients to see if labelled fibrin would appear in the kidney during episodes of rejection. Thirtyone patients with cadaveric renal transplants were studied by this technique.
Intravascular deposits of fibrin have been noted in histological sections of rejected renal transplants (Porter 1967) . In this study radioactive fibrinogen was administered to human transplant recipients to see if labelled fibrin would appear in the kidney during episodes of rejection. Thirtyone patients with cadaveric renal transplants were studied by this technique.
Methods
125I-fibrinogen (obtained from Radiochemical Centre, Amersham) was injected intravenously in a dose of 90-130 ,uCi and measurements of radioactivity were made from points over the heart, renal transplant, bladder, contralateral iliac fossa and liver (Salaman 1970) . A few patients had a second injection and one a third. Uptake of radioactive iodine by the thyroid was blocked by the administration of potassium iodide, 50 mg daily for two weeks. Radioactive counting was performed daily for five days using a Pitman 235 portable scintillation ratemeter, and the counts registered over the transplant were expressed as a percentage of the counts over the heart.
Results
Thirty-seven tests were performed on the 31 patients, 17 of whom were oliguric as a result of ischmmic tubular necrosis. The patients with functioning transplants and with no evidence of rejection had low levels of transplant radioactivity, and the readings that were obtained were less than those obtained over the heart (transplant radioactivity <100 %). There were two exceptions, these being 2 patients who had high levels of transplant radioactivity despite normal renal function. Both had developed wound hkematomas and it is probable that by 'trapping' labelled fibrin in the region of the transplant the hmmatomas were responsible for the high levels of radioactivity that were recorded. Ten patients were investigated during episodes of rejection (diagnosed when there was a deterioration in renal function) and 6 had high levels of transplant radioactivity (130-250%). One patient who was receiving anticoagulant drugs failed to demonstrate a rise, however, as did 3 other recipients who were experiencing a much more insidious form of rejection.
Of the 17 patients with ischmmic tubular necrosis, 10 were found to be free of rejection from evidence obtained by renal biopsy, and from the fact that renal function recovered without recourse to antirejection therapy. Levels of transplant radioactivity were generally low in these patients, although in a few the maximum values were of the order of 110-120%. By contrast, the 7 patients shown to have rejection in addition to tubular necrosis had much higher levels of transplant radioactivity with maximum values of 135-270%.
Discussion and Conclusion
These studies have shown that radioactive fibrinogen is deposited within renal transplants during episodes of acute rejection. However, this could not be demonstrated in cases of chronic rejection or in a patient taking anticoagulant drugs. Two 'false positive' results were obtained as a result of recent hemorrhage into the transplant wound. In the group of recipients with acute tubular necrosis, the test enabled those patients with super-added rejection to be identified and treated. Since it has hitherto been difficult to diagnose rejection in cadaver transplants during the early oliguric phase, the test would seem to be of particular value under these circumstances.
Summary 1251-labelled fibrinogen was given intravenously to 31 recipients of cadaveric renal transplants.
Increased levels of radioactivity (>1200% of heart count) were found over transplants which were undergoing rejection. During periods of acute tubular necrosis the administration of radioactive fibrinogen was helpful in indicating which recipients were undergoing rejection and it is suggested that a test of this kind could be most useful in the management of renal transplant recipients.
